HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ng, M K C
Right arrow Articles by Celermajer, D S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ng, M K C
Right arrow Articles by Celermajer, D S
Heart 2004;90:829-830
© 2004 by BMJ Publishing Group & British Cardiac Society


EDITORIAL

Glucocorticoid treatment and cardiovascular disease

M K C Ng*, D S Celermajer*

Department of Medicine, University of Sydney, Australia

Correspondence to:
Correspondence to:
Professor David S Celermajer
Department of Cardiology, Royal Prince Alfred Hospital, Camperdown, Sydney, NSW 2050, Australia; david.celermajer{at}email.cs.nsw.gov.au


ABSTRACT
The propensity of glucocorticoids to produce hyperglycaemia, hypertension, dyslipidaemia, and central obesity has long been a cause for concern among physicians regarding possible adverse cardiovascular events. Should heart failure be added to this list of concerns?


Keywords: glucocorticoids; hyperglycaemia; hypertension; dyslipidaemia; heart failure




This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
J. E. Goodwin, J. Zhang, and D. S. Geller
A Critical Role for Vascular Smooth Muscle in Acute Glucocorticoid-Induced Hypertension
J. Am. Soc. Nephrol., July 1, 2008; 19(7): 1291 - 1299.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
Q. M. Chen, D. Alexander, H. Sun, L. Xie, Y. Lin, J. Terrand, S. Morrissy, and S. Purdom
Corticosteroids Inhibit Cell Death Induced by Doxorubicin in Cardiomyocytes: Induction of Antiapoptosis, Antioxidant, and Detoxification Genes
Mol. Pharmacol., June 1, 2005; 67(6): 1861 - 1873.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2004 BMJ Publishing Group Ltd & British Cardiovascular Society